Journal of Investigative Surgery,
Journal Year:
2024,
Volume and Issue:
37(1)
Published: Oct. 28, 2024
Fracture
healing
can
be
impeded
or
even
compromised
by
various
factors,
resulting
in
a
growing
number
of
patients
suffering.
The
lncRNA
LINC-PINT
has
garnered
attention
for
its
latent
role
enhancing
fracture
healing,
but
specific
functions
this
process
remain
unclear.
iScience,
Journal Year:
2024,
Volume and Issue:
27(6), P. 109979 - 109979
Published: May 15, 2024
This
review
explores
the
hallmarks
of
cancer
resistance,
including
drug
efflux
mediated
by
ATP-binding
cassette
(ABC)
transporters,
metabolic
reprogramming
characterized
Warburg
effect,
and
dynamic
interplay
between
cells
mitochondria.
The
role
stem
(CSCs)
in
treatment
resistance
regulatory
influence
non-coding
RNAs,
such
as
long
RNAs
(lncRNAs),
microRNAs
(miRNAs),
circular
(circRNAs),
are
studied.
chapter
emphasizes
future
directions,
encompassing
advancements
immunotherapy,
strategies
to
counter
adaptive
integration
artificial
intelligence
for
predictive
modeling,
identification
biomarkers
personalized
treatment.
comprehensive
exploration
these
provides
a
foundation
innovative
therapeutic
approaches,
aiming
navigate
complex
landscape
enhance
patient
outcomes.
Molecular Therapy — Nucleic Acids,
Journal Year:
2024,
Volume and Issue:
35(2), P. 102184 - 102184
Published: March 30, 2024
Nonalcoholic
steatohepatitis
(NASH)
represents
a
severe
disease
subtype
of
nonalcoholic
fatty
liver
(NAFLD)
that
is
thought
to
be
highly
associated
with
systemic
metabolic
abnormalities.
It
characterized
by
series
substantial
damage,
including
hepatocellular
steatosis,
inflammation,
and
fibrosis.
The
end
stage
NASH,
in
some
cases,
may
result
cirrhosis
carcinoma
(HCC).
Nowadays
large
number
investigations
are
actively
under
way
test
various
therapeutic
strategies,
emerging
oligonucleotide
drugs
(e.g.,
antisense
oligonucleotide,
small
interfering
RNA,
microRNA,
mimic/inhibitor
activating
RNA)
have
shown
high
potential
treating
this
fatal
disease.
This
article
systematically
reviews
the
pathogenesis
NASH/NAFLD,
promising
druggable
targets
proven
current
studies
chemical
compounds
or
biological
drug
development,
feasibility
limitations
oligonucleotide-based
approaches
clinical
pre-clinical
studies.
Frontiers in Oncology,
Journal Year:
2024,
Volume and Issue:
14
Published: June 17, 2024
The
substantial
heterogeneity
exhibited
by
head
and
neck
cancer
(HNC),
encompassing
diverse
cellular
origins,
anatomical
locations,
etiological
contributors,
combined
with
the
prevalent
late-stage
diagnosis,
poses
significant
challenges
for
clinical
management.
Genomic
sequencing
endeavors
have
revealed
extensive
alterations
in
key
signaling
pathways
that
regulate
proliferation
survival.
Initiatives
to
engineer
therapies
targeting
these
dysregulated
are
underway,
several
candidate
molecules
progressing
evaluation
phases,
including
FDA
approval
agents
like
EGFR-targeting
monoclonal
antibody
cetuximab
K-RAS
wild-type,
EGFR-mutant
HNSCC
treatment.
Non-coding
RNAs
(ncRNAs),
owing
their
enhanced
stability
biological
fluids
important
roles
intracellular
intercellular
within
HNC
contexts,
now
recognized
as
potent
biomarkers
disease
management,
catalyzing
further
refined
diagnostic
therapeutic
strategies,
edging
closer
personalized
medicine
desideratum.
Enhanced
comprehension
of
genomic
immunological
landscapes
characteristic
is
anticipated
facilitate
a
more
rigorous
assessment
targeted
benefits
limitations,
optimize
deployment,
foster
innovative
advancements
treatment
approaches.
This
review
presents
an
update
on
molecular
mechanisms
mutational
spectrum
driving
oncogenesis
malignancies
explores
implications
advancing
methodologies
precision
therapeutics.
The Journal of Gene Medicine,
Journal Year:
2023,
Volume and Issue:
26(1)
Published: Oct. 28, 2023
Abstract
Introduction
Renal
cell
carcinoma
(RCC)
is
a
grave
malignancy
that
poses
significant
global
health
burden
with
over
400,000
new
cases
annually.
Disulfidptosis,
newly
discovered
programmed
death
process,
linked
to
the
actin
cytoskeleton,
which
plays
vital
role
in
maintaining
shape
and
survival.
The
of
disulfidptosis
poorly
depicted
clear
histologic
variant
RCC
(ccRCC).
Methods
Three
sets
ccRCC
cohorts,
ICGC_RECA‐EU
(
n
=
91),
GSE76207
32)
TCGA‐KIRC
607),
were
included
our
study,
batch
effect
was
removed
using
“combat”
function.
Correlation
calculated
“rcorr”
function
“Hmisc”
package
for
Pearson
analysis,
visualized
“pheatmap”
package.
Principal
component
analysis
performed
by
“vegan”
package,
“scatterplot3d”
Long
non‐coding
RNAs
(lncRNAs)
associated
screened
out
least
absolute
shrinkage
selection
operator
(LASSO)
COX
analysis.
Tumor
mutation,
immune
landscaping
immunotherapy
prediction
further
characterization
two
risk
groups.
Results
A
total
1822
disulfidptosis‐related
lncRNAs
selected,
among
308
found
be
significantly
clinical
outcome
patients.
We
retained
11
lncRNAs,
namely,
AP000439.3,
RP11‐417E7.1,
RP11‐119D9.1,
LINC01510,
SNHG3,
AC156455.1,
RP11‐291B21.2,
EMX2OS,
AC093850.2,
HAGLR
RP11‐389C8.2,
through
LASSO
prognosis
model
construction,
displayed
satisfactory
accuracy
(area
under
curve,
AUC,
values
all
above
0.6
multiple
cohorts)
stratification
prognosis.
nomogram
constructed
integrating
factors
score,
enhanced
efficacy
(AUC
0.7
cohorts).
patients
male
gender,
higher
stages
advanced
pathological
T
stage
inclined
have
score
values.
Dactinomycin_1911,
Vinblastine_1004,
Daporinad_1248
Vinorelbine_2048
identified
as
promising
candidate
drugs
treating
value.
Moreover,
value
prone
resistant
immunotherapy.
Conclusion
developed
predicting
based
on
selected
verified
different
cohorts.
Furthermore,
we
delineated
an
intricate
portrait
tumor
topography
pharmacosensitivity
evaluations
within
disparate
stratifications.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: July 12, 2024
Objective
Ferroptosis
and
necroptosis
are
two
recently
identified
forms
of
non-apoptotic
cell
death.
Their
dysregulation
plays
a
critical
role
in
the
development
progression
Psoriasis
(PsD)
Atherosclerosis
(AS).
This
study
explores
shared
necroptosis-related
genes
elucidates
their
molecular
mechanisms
PsD
AS
through
analysis
public
databases.
Methods
Data
sets
for
(GSE30999)
(GSE28829)
were
retrieved
from
GEO
database.
Differential
gene
expression
(DEG)
weighted
co-expression
network
(WGCNA)
performed.
Machine
learning
algorithms
candidate
biomarkers,
whose
diagnostic
values
assessed
using
Receiver
Operating
Characteristic
(ROC)
curve
analysis.
Additionally,
levels
these
biomarkers
models
quantitatively
measured
Western
Blot
(WB)
real-time
quantitative
PCR
(RT-qPCR).
Furthermore,
CIBERSORT
evaluated
immune
infiltration
tissues,
highlighting
correlation
between
characteristic
cells.
Predictive
drugs
targeting
was
conducted
DGIdb
database,
an
lncRNA-miRNA-mRNA
related
to
constructed.
Results
We
44
differentially
expressed
ferroptosis-related
(DE-FRGs)
30
(DE-NRGs).
GO
KEGG
enrichment
analyses
revealed
significant
immune-related
inflammatory
pathways,
especially
NOD-like
receptor
TNF
signaling
pathways.
Two
(NAMPT,
ZFP36)
eight
(C7,
CARD6,
CASP1,
CTSD,
HMOX1,
NOD2,
PYCARD,
TNFRSF21)
showed
high
sensitivity
specificity
ROC
These
findings
corroborated
external
validation
datasets
models.
Immune
increased
T
cells
gamma
delta,
Macrophages
M0,
M2
samples.
we
43
5
genes.
Notably,
XIST-miR-93–5p-ZFP36/HMOX1
NEAT1-miR-93–5p-ZFP36/HMOX1
pathways
have
been
as
promising
RNA
regulatory
PsD.
Conclusion
The
potential
key
AS.
significantly
influence
pathogenesis
by
modulating
macrophage
activity,
participating
regulation,
mediating
responses.
Animal Cells and Systems,
Journal Year:
2025,
Volume and Issue:
29(1), P. 135 - 148
Published: Feb. 11, 2025
Circadian
rhythms
are
24-hour
cycles
in
various
biological
processes,
such
as
sleep,
wake,
and
hormone
secretion,
controlled
by
an
internal
clock.
Disruption
of
circadian
has
been
related
to
human
diseases.
Abnormal
expression
rhythm-related
genes,
CLOCK,
BMAL1,
PER1,
PER2,
CRY1,
CRY2,
RORα,
NPAS2,
REV-ERBα
TIMELESS
also
reported
be
associated
with
cancer.
NPAS2
cancer
development.
In
contrast,
RORα
inhibit
development
progression.
Furthermore,
studies
suggest
that
genes
can
regulated
ncRNAs
miRNAs,
lncRNAs
circRNAs
dysregulation
these
contributes
Here,
we
summarize
the
mechanisms
whereby
ncRNA
leads
abnormal
several
cancers
gene-associated
regulatory
contribute
resistance
chemo
–
radiotherapy.
This
review
provides
insights
into
mechanistic
involvements
network
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(5), P. 2126 - 2126
Published: Feb. 27, 2025
Melanoma
is
the
deadliest
form
of
skin
cancer,
and
its
treatment
poses
significant
challenges
due
to
aggressive
nature
resistance
conventional
therapies.
Long
non-coding
RNAs
(lncRNAs)
represent
a
new
frontier
in
search
for
suitable
targets
control
melanoma
progression
invasiveness.
Indeed,
lncRNAs
exploit
wide
range
regulatory
functions
along
chromatin
remodeling,
gene
transcription,
post-transcription,
transduction,
post-transduction
ultimately
tune
multiple
cellular
processes.
The
understanding
this
intricate
flexible
network
orchestrated
by
pathological
conditions
can
strategically
support
rational
identification
promising
targets,
speeding
up
setup
therapeutics
integrate
currently
available
approaches.
Here,
most
recent
findings
on
involved
will
be
analyzed.
In
particular,
functional
links
between
their
mechanisms
action
some
frequently
underestimated
features,
like
different
subcellular
localizations,
highlighted.
Discover Oncology,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: March 6, 2025
lncRNAs
are
key
regulators
in
thyroid
cancer
(TC).
While
lncRNA
ACVR2B-AS1
has
been
proposed
as
a
potential
TC
biomarker,
its
role
remains
underexplored.
This
study
aims
to
clarify
clinical
significance
and
investigate
molecular
mechanism.
qRT-PCR
was
used
assess
the
expression
of
tissues
cell
lines.
Kaplan-Meier
survival
curves
Cox
regression
were
utilized
prognostic
value
expression.
The
interaction
between
miR-195-5p,
well
their
effects
on
viability,
migration,
invasion,
evaluated
using
dual-luciferase
reporter
assays,
CCK-8
Transwell
assays.
significantly
upregulated
lines,
correlated
with
TNM
stage
lymph
node
metastasis.
Elevated
levels
associated
poor
outcomes,
it
identified
an
independent
risk
factor
for
progression.
A
direct
regulatory
relationship
established
negatively
regulating
thereby
promoting
proliferation,
invasion.
FGF2
predicted
validated
target
gene
miR-195-5p.
shows
marker
may
regulate
tumor
progression
through
miR-195-5p/FGF2
axis,
offering
new
insights
diagnosis
treatment.
Discover Oncology,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: March 8, 2025
Colorectal
cancer
(CRC)
is
the
second
leading
cause
of
cancer-related
mortality.
Using
Galaxy
platform,
present
study
aimed
to
assess
differentially
expressed
genes
(DEGs)
in
CRC
patients.
The
expression
data
was
obtained
from
Gene
Expression
Omnibus
database
(GSE137327).
DEGs
were
analyzed
using
Ontology
(GO)
and
GeneMANIA
databases
detect
most
critical
biological
pathways
processes.
Protein–Protein
Interaction
Studies
(PPIS)
identified
four
hub
(CCN1,
CCL2,
FLNC,
MYH11).
This
article
presents
findings
on
three
mRNAs
(CEMIP,
MMP7,
DPEP1)
also
two
notable
lncRNAs,
EVADR
DLX6-AS1,
that
have
an
impact
pathogenesis
play
a
role
epithelial-mesenchymal
transition
tumor
cells.
lncRNAs
are
putative
therapeutic
targets
diagnostic
markers.
For
instance,
CRISPR/Cas9
editing
systems
can
be
designed
order
modulate
these
genes,
or
edit
them
for
purpose
inducing
sensitivity
conventional
therapies.
Besides,
incorporated
into
clinical
prognostic
models,
offering
panels
choose
appropriate
personalized
methods
treatment.
Together,
represent
novel
markers
possible
CRC.